Vitamin D Receptor Polymorphisms Predispose to Primary Biliary Cirrhosis and Severity of the Disease in Polish Population

Overview

Journal Gastroenterol Res Pract

Publisher Wiley

Specialty Gastroenterology

Date 2012 Jun 13

PMID 22690210

Citations 15

Authors

Agnieszka Kempinska-Podhorecka

Ewa Wunsch

Tomasz Jarowicz

Joanna Raszeja-Wyszomirska

Beata Loniewska

Mariusz Kaczmarczyk

Malgorzata Milkiewicz

Piotr Milkiewicz

Affiliations

Soon will be listed here.

Abstract

Primary biliary cirrhosis (PBC) is a chronic cholestatic liver condition characterized by the immune-mediated damage of the intrahepatic bile ducts. Polymorphisms of vitamin D receptor (VDR) are considered to contribute to its pathogenesis however their incidence varies in different populations and their potential association with the course of the disease has not been studied. In this paper we investigated the incidence and correlation of three VDR polymorphisms (BsmI, ApaI or TaqI) with various clinical, biochemical, and serological factors in a homogenous group of 143 Caucasian patients with PBC. Control group comprises 306 DNA samples from umbilical cord blood of healthy newborn children. When compared to controls, we observed a significant dominance of the b allele in the BsmI (OR = 1.69 [1.27-2.24]; P = 0.0003) and t allele in the TaqI (OR = 0.62 [0.47-0.82], P = 0.0001) in patients with PBC. Moreover the BsmI and TaqI polymorphisms were associated with the presence of advanced fibrosis/liver cirrhosis at the diagnosis of PBC. Pairwise linkage disequilibrium (LD) calculations proved that the analyzed SNPs are within an LD block (100% of LDs were D'>0.9). Our study showed, for the first time, that the analyzed polymorphisms of VRD may exert an effect on a natural history of PBC.

Citing Articles

The Influence of Single Nucleotide Polymorphisms on Vitamin D Receptor Protein Levels and Function in Chronic Liver Disease.

Tourkochristou E, Tsounis E, Tzoupis H, Aggeletopoulou I, Tsintoni A, Lourida T Int J Mol Sci. 2023; 24(14).

PMID: 37511164 PMC: 10380285. DOI: 10.3390/ijms241411404.

Association of Vitamin D Gene Polymorphisms With HCV Infection Outcome.

Neamatallah M, Serria M, El-Bendary M, El-Gilany A, Alhawarey A, Abed S Br J Biomed Sci. 2022; 79:10237.

PMID: 35996514 PMC: 8983825. DOI: 10.3389/bjbs.2021.10237.

Vitamin D-VDR Novel Anti-Inflammatory Molecules-New Insights into Their Effects on Liver Diseases.

Aggeletopoulou I, Thomopoulos K, Mouzaki A, Triantos C Int J Mol Sci. 2022; 23(15).

PMID: 35955597 PMC: 9369388. DOI: 10.3390/ijms23158465.

Vitamin-D Receptor-Gene Polymorphisms Affect Quality of Life in Patients with Autoimmune Liver Diseases.

Kempinska-Podhorodecka A, Adamowicz M, Chmielarz M, Janik M, Milkiewicz P, Milkiewicz M Nutrients. 2020; 12(8).

PMID: 32727130 PMC: 7469002. DOI: 10.3390/nu12082244.

Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis.

Triantos C, Aggeletopoulou I, Kalafateli M, Spantidea P, Vourli G, Diamantopoulou G Sci Rep. 2018; 8(1):14065.

PMID: 30218108 PMC: 6138740. DOI: 10.1038/s41598-018-32482-3.

References

Fan L, Tu X, Zhu Y, Zhou L, Pfeiffer T, Feltens R . Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol. 2005; 20(2):249-55. DOI: 10.1111/j.1440-1746.2005.03532.x. View

. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009; 51(2):237-67. DOI: 10.1016/j.jhep.2009.04.009. View

Lemire J, Archer D, Beck L, Spiegelberg H . Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr. 1995; 125(6 Suppl):1704S-1708S. DOI: 10.1093/jn/125.suppl_6.1704S. View

Cutolo M, Pizzorni C, Sulli A . Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun Rev. 2011; 11(2):84-7. DOI: 10.1016/j.autrev.2011.08.003. View

Cantorna M, WOODWARD W, Hayes C, DeLuca H . 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol. 1998; 160(11):5314-9. View

Milkiewicz P, Buwaneswaran H, Coltescu C, Shums Z, Norman G, Heathcote E . Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease. Clin Gastroenterol Hepatol. 2009; 7(12):1355-60. DOI: 10.1016/j.cgh.2009.07.012. View

Mells G, Floyd J, Morley K, Cordell H, Franklin C, Shin S . Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet. 2011; 43(4):329-32. PMC: 3071550. DOI: 10.1038/ng.789. View

Neuberger J . Primary biliary cirrhosis. Lancet. 1997; 350(9081):875-9. DOI: 10.1016/S0140-6736(97)05419-6. View

Pares A, Guanabens N, Rodes J . Gene polymorphisms as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 2005; 17(3):311-5. DOI: 10.1097/00042737-200503000-00009. View

10.

Pelajo C, Lopez-Benitez J, Miller L . Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev. 2010; 9(7):507-10. DOI: 10.1016/j.autrev.2010.02.011. View

11.

Tanaka A, Nezu S, Uegaki S, Kikuchi K, Shibuya A, Miyakawa H . Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J Hepatol. 2009; 50(6):1202-9. DOI: 10.1016/j.jhep.2009.01.015. View

12.

Faraco J, Morrison N, Baker A, Shine J, Frossard P . ApaI dimorphism at the human vitamin D receptor gene locus. Nucleic Acids Res. 1989; 17(5):2150. PMC: 317576. DOI: 10.1093/nar/17.5.2150. View

13.

Willheim M, Thien R, Schrattbauer K, Bajna E, Holub M, Gruber R . Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab. 1999; 84(10):3739-44. DOI: 10.1210/jcem.84.10.6054. View

14.

Harada K, Nakanuma Y . Biliary innate immunity and cholangiopathy. Hepatol Res. 2007; 37 Suppl 3:S430-7. DOI: 10.1111/j.1872-034X.2007.00247.x. View

15.

Uitterlinden A, Fang Y, van Meurs J, Pols H, van Leeuwen J . Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2):143-56. DOI: 10.1016/j.gene.2004.05.014. View

16.

Carlberg C . Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res. 2003; 164:29-42. DOI: 10.1007/978-3-642-55580-0_2. View

17.

Invernizzi P, Selmi C, Poli F, Frison S, Floreani A, Alvaro D . Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology. 2008; 48(6):1906-12. PMC: 2592501. DOI: 10.1002/hep.22567. View

18.

Morrison N, Yeoman R, Kelly P, Eisman J . Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A. 1992; 89(15):6665-9. PMC: 49563. DOI: 10.1073/pnas.89.15.6665. View

19.

Norman A . From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008; 88(2):491S-499S. DOI: 10.1093/ajcn/88.2.491S. View

20.

Gershwin M, Mackay I, Sturgess A, Coppel R . Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol. 1987; 138(10):3525-31. View